The HIT Lab is attempting to explore the effects of continuous glucose monitoring on adults with type I diabetes. We propose that continuous glucose monitoring will reduce the number of nocturnal hypoglycemic excursions, time spent in nocturnal hypoglycemia, and duration of nocturnal hypoglycemic excursions.  Other benefits of continuous glucose monitoring include improvement in patient’s overall HbA1C, maintaining euglycemia, and better quality of life.